Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph R Pisegna

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Current Gastroenterology Reports|November 12, 2009
Do COX-2 inhibitors reduce metachronous cancer development?Joseph R Pisegna
Pharmacotherapy|November 1, 2003
Treating patients with acute gastrointestinal bleeding or rebleedingJoseph R Pisegna
Critical Care Medicine|June 20, 2002
Pharmacology of acid suppression in the hospital setting: focus on proton pump inhibitionJoseph R Pisegna
The American Journal of Gastroenterology|August 4, 2023
Diagnosis and Treatment Design Strategy for Gastric NeoplasiaJoseph R Pisegna
Current Gastroenterology Reports|November 14, 2008
Is surveillance upper endoscopy indicated for gastric ulcers?Joseph R Pisegna
Expert Opinion on Pharmacotherapy|January 26, 2006
The role of proton pump inhibitors in the treatment of Zollinger-Ellison syndromeJose M Nieto, Joseph R Pisegna
Current Treatment Options in Gastroenterology|March 12, 2003
Pharmacologic Treatment of Upper Gastrointestinal BleedingDavid S. Oh, Joseph R. Pisegna
Journal of Clinical Gastroenterology|December 16, 2004
Acid suppression in the perioperative periodJoseph R Pisegna, Robert G Martindale
Alimentary Pharmacology & Therapeutics|October 29, 2020
Editorial: tegoprazan-the newest advance in the management of acid-related diseasesElizabeth A Marcus, Joseph R Pisegna
Current Opinion in Endocrinology, Diabetes, and Obesity|October 18, 2007
Pituitary adenylate cyclase-activating polypeptide: a novel peptide with protean implicationsJoseph R Pisegna, David S Oh
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Current Gastroenterology Reports|November 12, 2009
Do COX-2 inhibitors reduce metachronous cancer development?Joseph R Pisegna
Pharmacotherapy|November 1, 2003
Treating patients with acute gastrointestinal bleeding or rebleedingJoseph R Pisegna
Critical Care Medicine|June 20, 2002
Pharmacology of acid suppression in the hospital setting: focus on proton pump inhibitionJoseph R Pisegna
The American Journal of Gastroenterology|August 4, 2023
Diagnosis and Treatment Design Strategy for Gastric NeoplasiaJoseph R Pisegna
Current Gastroenterology Reports|November 14, 2008
Is surveillance upper endoscopy indicated for gastric ulcers?Joseph R Pisegna
Expert Opinion on Pharmacotherapy|January 26, 2006
The role of proton pump inhibitors in the treatment of Zollinger-Ellison syndromeJose M Nieto, Joseph R Pisegna
Current Treatment Options in Gastroenterology|March 12, 2003
Pharmacologic Treatment of Upper Gastrointestinal BleedingDavid S. Oh, Joseph R. Pisegna
Journal of Clinical Gastroenterology|December 16, 2004
Acid suppression in the perioperative periodJoseph R Pisegna, Robert G Martindale
Alimentary Pharmacology & Therapeutics|October 29, 2020
Editorial: tegoprazan-the newest advance in the management of acid-related diseasesElizabeth A Marcus, Joseph R Pisegna
Current Opinion in Endocrinology, Diabetes, and Obesity|October 18, 2007
Pituitary adenylate cyclase-activating polypeptide: a novel peptide with protean implicationsJoseph R Pisegna, David S Oh
Pageof 11